Welcome to our dedicated page for So-Young Intl news (Ticker: SY), a resource for investors and traders seeking the latest updates and insights on So-Young Intl stock.
So-Young International Inc. reports on its China aesthetic treatment platform, which connects consumers with online services and offline treatments through digital access points and branded aesthetic centers. Company updates cover curated treatment information, online reservations, aesthetic treatment services, and the development, production and distribution of optoelectronic medical equipment and injectable products.
Recurring news themes include quarterly and annual results, branded center expansion, platform transaction activity, treatment visits, active users, member activity, and operating performance across medical aesthetics services. So-Young also reports foreign-issuer and ADS-related matters, including annual Form 20-F filing announcements and completed Nasdaq listing compliance updates.
So-Young International (Nasdaq: SY), China's leading aesthetic treatment platform, has successfully regained compliance with Nasdaq's minimum bid price requirement. The company received confirmation from Nasdaq on July 2, 2025, after maintaining a closing bid price of $1.00 or higher for its American depositary shares (ADSs) for 10 consecutive business days from June 17 to July 1, 2025.
This development resolves the compliance issue that began on August 28, 2024, when So-Young was initially notified of non-compliance. The company had received two compliance periods: an initial 180-day period until February 24, 2025, followed by an extension until August 25, 2025. With this requirement now met, Nasdaq has closed the matter.
So-Young International Inc. (NASDAQ: SY), China's leading aesthetic treatment platform, has scheduled its first quarter 2025 financial results announcement for May 16, 2025, before U.S. markets open. The company will host an earnings conference call on the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until March 23, 2025, and interested parties can also access a live and archived webcast of the conference call through the company's investor relations website.
So-Young International (Nasdaq: SY), China's leading aesthetic treatment platform, has announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2024. The report was submitted to the Securities and Exchange Commission on April 18, 2025.
The annual report is accessible through the company's investor relations website at ir.soyoung.com. Shareholders and ADS holders can request a complimentary hard copy of the annual report, which includes audited consolidated financial statements, by emailing ir@soyoung.com.
So-Young International (Nasdaq: SY), China's leading aesthetic treatment platform, announced that its CEO and chairman Mr. Xing Jin, through Beauty & Health Holdings , has purchased 4,544,820 American depositary shares (ADSs) representing 3,496,015.38 Class A ordinary shares in the open market on March 31, 2025.
The purchase was made at US$0.90 per ADS, totaling US$4,090,338, using personal funds. This transaction increased Jin's beneficial ownership to 24.9% of the company's outstanding shares. The purchase was executed in accordance with Rule 10b-18 of the Securities Exchange Act of 1934.
The company's directors stated that the share purchase is not expected to materially impact So-Young's financial position or business operations. Jin expressed that this purchase reflects his continued confidence in the company's long-term growth prospects.
So-Young International (SY) reported its Q4 and FY2024 financial results, showing mixed performance. Q4 total revenues decreased 5.5% to RMB369.2 million (US$50.6 million) compared to 2023. The company recorded a significant net loss of RMB607.6 million (US$83.2 million), primarily due to a one-time goodwill impairment charge of RMB540.0 million for Wuhan Miracle subsidiary.
Notable operational highlights include the expansion to 19 aesthetic centers across nine major cities, with 11 centers achieving positive monthly operating cash flow. Aesthetic treatment services revenue grew substantially by 701.6% to RMB81.3 million. The company maintains a 60% customer retention rate and served over 1,200 institutions with supply chain solutions.
The board declared a special cash dividend of US$0.03445 per ordinary share (US$0.0265 per ADS), with approximately US$3 million total distribution planned for April 25, 2025.
So-Young International (NASDAQ: SY), China's largest medical aesthetics social community, has announced a rescheduling of its Q4 and full year 2024 financial results release. The results will now be presented before U.S. markets open on March 28, 2025, followed by a management earnings conference call at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time) on the same day.
So-Young International (NASDAQ: SY), China's leading social community platform in the medical aesthetics industry, has announced it will release its Q4 and full year 2024 financial results on March 20, 2025, before U.S. markets open.
The company will host an earnings conference call on the same day at 7:30 AM U.S. Eastern Time (7:30 PM Beijing/Hong Kong Time). A telephone replay will be available until March 27, 2025, and interested parties can also access the webcast through the company's investor relations website.